课题基金 / 基金详情

Genes Regulated By Abused Drugs

Genes Regulated By Abused Drugs
受滥用药物调节的基因
批准号:
6827527
负责人:
George Richard Uhl
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

George Richard Uhl的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abused drugs produce long-lasting changes in behaviors via biochemical mechanisms that are largely unknown. Drug-altered changes in expression of specific genes in the brain can provide a major window on possible biochemical substrates for ddiction. To further explore this area, we are now increasingly focused on array hybridization techniques that has allow identification of dozens of distinct cDNAs that correspond to candidate drug- regulated genes expressed in brain. During this year, we have enhanced characterization of candidate genes whose expression is regulated by amphetamine, cocaine and morphine. We have identified a human haplotype in the morphine-regulated gene, NrCAM, that is associated with human substance abuse vulnerability in human genome scanning studies from this laboratory. During this year, we have reported the KEPI gene. We have also identified a relative of this initial morphine-upregulated gene, KEPI, that we have termed "GBPI" as a second protein-kinase-C dependent phosphoprotein whose phosphorylation causes it to become a powerful inhibitor of protein phosphatase 1 activity and is expressed in gut and in brain. Using microarrays, we have been able to detect reproducible positive hybridization signals from ca 38% of the genes sampled oligonucleotide DNA microarrays, and to identify the ca 1-2% that are reproducibly regulated more than 2-fold by knockouts or drugs. We have characterized amphetamine-induced changes as upregualating a number of genes acutely and downregulating them chronically, in work accepted for publication in this year. These data provide powerful substrates for further convergence with studies of human drug abuse vulnerability genome scans and with studies of mechanisms of addiction neurobiology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PTPRD phosphatase inhibitors for stimulant use disorders
  • 批准号:
    10710969
  • 项目类别:
  • 资助金额:
    $38.63万
  • 财政年份:
    2022
  • 负责人:
    George Richard Uhl
  • 依托单位:
PTPRD phosphatase inhibitors for stimulant use disorders
  • 批准号:
    10653070
  • 项目类别:
  • 资助金额:
    $139.15万
  • 财政年份:
    2022
  • 负责人:
    George Richard Uhl
  • 依托单位:
PTPRD phosphatase inhibitors for stimulant use disorders
  • 批准号:
    10457132
  • 项目类别:
  • 资助金额:
    $145.39万
  • 财政年份:
    2022
  • 负责人:
    George Richard Uhl
  • 依托单位:
PTPRD ligands for stimulant and opiate use disorders
国内基金
海外基金
热应激通过Ca²⁺/Calcineurin/DRP1轴诱导心肌损伤与室性心律失常的分子机制研究
Ca2+驱动的Calcineurin/LATS1信号重塑糖有氧氧化进程在B1AR自身抗体诱导心房重构中的机制研究
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    孙华鑫
  • 依托单位:
乳酸通过Ca2+/Calcineurin/TFEB信号轴在氧化应激诱导视网膜退行性变中的作用机制研究
  • 批准号:
    --
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    韩小建
  • 依托单位:
Ca2+驱动的Calcineurin/LATS1信号重塑糖有氧氧化进程在β1AR自身抗体诱导心房重构中的机制研究
  • 批准号:
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    孙华鑫
  • 依托单位: